9FQ.F Plant Advanced Technologies SA

Healthcare Biotechnology Frankfurt Exchange
3.40 EUR
Close of Nov 11, 2026
3.08 8.24
Market cap
EUR 3.87M
P/E
5.7x
P/B
0.39x
ROE
5.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 9FQ.F undervalued?

Graham number

The Graham number of Plant Advanced Technologies SA cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Plant Advanced Technologies SA fundamental analysis

No fundamental analysis for Plant Advanced Technologies SA yet.

Plant Advanced Technologies SA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Plant Advanced Technologies SA

Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include Process PAT Exudactive a sustainable sourcing solution to produce your exclusive, personalized Exudactive; and PAT Target Binding, which finds the ligands that bind to the protein targets of interest, such as enzymes. Plant Advanced Technologies SA was incorporated in 2005 and is headquartered in …

Full company profile